273 related articles for article (PubMed ID: 34256852)
1. Complete remission in metastatic primary malignant melanoma of the esophagus with nivolumab: a case report.
Okamoto T; Nakano E; Yamauchi T
J Med Case Rep; 2021 Jul; 15(1):345. PubMed ID: 34256852
[TBL] [Abstract][Full Text] [Related]
2. Primary malignant melanoma of the esophagus successfully treated with nivolumab: a case report.
Ito S; Tachimori Y; Terado Y; Sakon R; Narita K; Goto M
J Med Case Rep; 2021 May; 15(1):237. PubMed ID: 33947459
[TBL] [Abstract][Full Text] [Related]
3. Primary malignant melanoma of the esophagus, treated with immunotherapy: a case report.
Rochefort P; Roussel J; de la Fouchardière A; Sarabi M; Desseigne F; Guibert P; Cattey-Javouhey A; Mastier C; Neidhardt-Berard EM; de la Fouchardière C
Immunotherapy; 2018 Aug; 10(10):831-835. PubMed ID: 30073896
[TBL] [Abstract][Full Text] [Related]
4. Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review.
McDonald MA; Sanghvi P; Bykowski J; Daniels GA
BMC Cancer; 2018 May; 18(1):549. PubMed ID: 29743050
[TBL] [Abstract][Full Text] [Related]
5. A case of long-term survival treated with three metastasectomies and two subsequent adjuvant nivolumab therapies for recurrent malignant melanoma of the esophagus.
Hanada K; Tsunoda S; Nomura M; Fujimura S; Yutaka Y; Nishigori T; Hisamori S; Maekewa H; Hoshino N; Itami A; Tanaka E; Obama K
Surg Case Rep; 2022 Nov; 8(1):206. PubMed ID: 36333558
[TBL] [Abstract][Full Text] [Related]
6. Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma.
Nomura M; Oze I; Masuishi T; Yokota T; Satake H; Iwasawa S; Kato K; Andoh M
Int J Clin Oncol; 2020 May; 25(5):972-977. PubMed ID: 31938955
[TBL] [Abstract][Full Text] [Related]
7. A case of primary malignant melanoma of the esophagogastric junction with abscopal effect after nivolumab administration.
Yamaguchi T; Fushida S; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Nakamura K; Ninomiya I; Inaki N
Surg Case Rep; 2021 Dec; 7(1):253. PubMed ID: 34882298
[TBL] [Abstract][Full Text] [Related]
8. Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.
Ozaki Y; Shindoh J; Miura Y; Nakajima H; Oki R; Uchiyama M; Masuda J; Kinowaki K; Kondoh C; Tanabe Y; Tanaka T; Haruta S; Ueno M; Kitano S; Fujii T; Udagawa H; Takano T
BMC Cancer; 2017 Nov; 17(1):778. PubMed ID: 29162045
[TBL] [Abstract][Full Text] [Related]
9. Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma.
Komatsu T; Konishi K; Aoshima M; Tokura Y; Nakamura K
Jpn J Radiol; 2018 Dec; 36(12):712-718. PubMed ID: 30206802
[TBL] [Abstract][Full Text] [Related]
10. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
11. A rare case of eosinophilic gastritis induced by nivolumab therapy for metastatic melanoma.
Tsuji A; Hiramatsu K; Namikawa S; Yamamoto A; Midori Y; Murata Y; Tanaka T; Nosaka T; Naito T; Takahashi K; Ofuji K; Matsuda H; Ohtani M; Imamura Y; Iino S; Hasegawa M; Nakamoto Y
Clin J Gastroenterol; 2022 Oct; 15(5):876-880. PubMed ID: 35978213
[TBL] [Abstract][Full Text] [Related]
12. Case Report: Sustained Remission Due to PD-1-Inhibition in a Metastatic Melanoma Patient With Depleted B Cells.
Wulfken LM; Becker JC; Hayajneh R; Wagner AD; Schaper-Gerhardt K; Flatt N; Grimmelmann I; Gutzmer R
Front Immunol; 2021; 12():733961. PubMed ID: 34675925
[TBL] [Abstract][Full Text] [Related]
13. Concealed complete response in melanoma patients under therapy with immune checkpoint inhibitors: two case reports.
Schliep S; Agaimy A; Cavallaro A; Kiesewetter F; Schuler G; Heinzerling L
J Immunother Cancer; 2018 Jan; 6(1):2. PubMed ID: 29332608
[TBL] [Abstract][Full Text] [Related]
14. Rapid complete remission of metastatic melanoma after first-line treatment with nivolumab plus tumor-infiltrating lymphocytes.
Zhao L; Yang Y; Li W; Han L; Lin H; Gao Q
Immunotherapy; 2018 Sep; 10(13):1133-1136. PubMed ID: 30236024
[TBL] [Abstract][Full Text] [Related]
15. Complete responses to two different anti-PD1 agents in a metastatic melanoma patient.
Kilickap S; Guven DC; Aktepe OH; Aktas BY; Dizdar O
J Oncol Pharm Pract; 2020 Mar; 26(2):496-499. PubMed ID: 31256744
[TBL] [Abstract][Full Text] [Related]
16. Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab.
Sakaguchi H; Tanimoto A; Sato S; Yanagimura N; Suzuki C; Takumi Y; Nishiyama A; Yamashita K; Takeuchi S; Ohtsubo K; Yano S
Intern Med; 2022 Jan; 61(1):75-79. PubMed ID: 34176837
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.
Yonezaki K; Kobayashi T; Imachi H; Yoshimoto T; Kikuchi F; Fukunaga K; Sato S; Ibata T; Yamaji N; Lyu J; Dong T; Murao K
J Med Case Rep; 2018 Jun; 12(1):171. PubMed ID: 29914537
[TBL] [Abstract][Full Text] [Related]
18. [Metastatic malignant melanoma of the urinary bladder presenting with hematuria: a case report].
Maeda T; Uchida Y; Kouda T; Matsui H; Kawahara Y; Sato T; Nakajima F
Hinyokika Kiyo; 2008 Dec; 54(12):787-90. PubMed ID: 19175003
[TBL] [Abstract][Full Text] [Related]
19. Primary Malignant Melanoma of the Gastroesophageal Junction Treated With Immunotherapy: A Case Report.
Attlassy N; Agbeh A; Patnaik R; Miller J; McCarthy J
WMJ; 2023 Mar; 122(1):77-80. PubMed ID: 36940130
[TBL] [Abstract][Full Text] [Related]
20. Tumor lysis syndrome in a patient with metastatic melanoma treated with nivolumab.
Sugimoto S; Terashima T; Yamashita T; Iida N; Kitahara M; Hodo Y; Shimakami T; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Shirota Y; Sato K; Mizukoshi E; Honda M; Harada K; Kaneko S
Clin J Gastroenterol; 2020 Oct; 13(5):935-939. PubMed ID: 32594423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]